Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 253-775-4 | CAS number: 38083-17-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2006-04-11 to 2006-10-20
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: study was conducted according to OECD 428 guideline and conducted under GLP conditions
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 428 (Skin Absorption: In Vitro Method)
- Principles of method if other than guideline:
- not applicable
- GLP compliance:
- yes
Test material
- Reference substance name:
- Climbazole
- EC Number:
- 253-775-4
- EC Name:
- Climbazole
- Cas Number:
- 38083-17-9
- Molecular formula:
- C15H17ClN2O2
- IUPAC Name:
- 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one
Constituent 1
- Radiolabelling:
- yes
Test animals
- Species:
- other: not applicable
- Strain:
- other: not applicable
- Details on test animals or test system and environmental conditions:
- not applicable
Administration / exposure
- Type of coverage:
- open
- Vehicle:
- other: Shampoo matrix
- Duration of exposure:
- 0.5 h
- Doses:
- 2% formulation was applied which was approximately 10 mg/cm2 (or 25.4 mg/cell; 200 μg crinipan/cm2)
- No. of animals per group:
- not applicable
- Details on study design:
- not applicable
- Details on in vitro test system (if applicable):
- One dose was prepared to mimic a shampoo formulation containing nominal 2% (w/w) crinipan. The standard crinipan and [14C]-radiolabelled crinipan were mixed to obtain a concentration of crinipan of 19.8 mg/g with a specific activity of 300 μCi/g. Human skin samples were obtained post mortem. The skin samples were cut at a thickness setting of 400μm using an electric dermatome. The type of static glass diffusion cell used in this study has an exposed membrane area of 2.54 cm2 and a volume of approximately 4.5 mL. Discs of approximately 3.3 cm diameter of prepared skin membrane were mounted. Diffusion cells containing intact skin membranes were selected to give 12 diffusion cells (plus 2 controls) from 4 subjects with 3 replicate samples per subject. The dose was applied as a nominal 2% formulation to the skin at a rate of 10 mg/cm2 (actual mean amount applied = 19.8 mg crinipan/g formulation; 198 μg crinipan/cm2). After 0.5 h of contact, a sample of receptor fluid was taken and fresh receptor fluid was added to replace the volume removed. The cells were returned to the water bath and sampling continued at recorded intervals throughout the exposure period (1, 2, 4, 6 & 24 h). To assess penetration through human stratum corneum, successively deeper layers of the stratum corneum were removed by the repeated application of adhesive tape to a maximum of 5 strips. All samples were analysed by LSC.
Results and discussion
- Absorption in different matrices:
- There was no penetration of crinipan through human skin during the 0.5 h contact period from the 2% shampoo formulation into the receptor fluid. Almost all the applied dose was washed off at 0.5 h (96.9%). A very small proportion of the dose, which had either penetrated into the stratum corneum and epidermis or was not washed off at 0.5 h, penetrated very slowly over the entire 24 h sampling period to give a penetration rate of 0.003 μg/cm²/h. There was a lag phase of approximately 4 h and the fastest rate of penetration was achieved between 6 and 24 h giving an penetration rate of 0.004 μg/cm²/h. At the end of the 24 h sampling period <1% of the applied dose was found in the final wash and <0.2% recovered in the stratum corneum (0.075%) and epidermis (0.109%). The total amount that penetrated over 24 h was 0.041% (0.081μg/cm²).
- Total recovery:
- At the end of the 24 h sampling period <1% of the applied dose was found in the final wash and <0.2% recovered in the stratum corneum (0.075%) and epidermis (0.109%). Approx. total 98% of the applied dose for was recovered.
Percutaneous absorption
- Dose:
- 2% formulation
- Parameter:
- percentage
- Absorption:
- 0 - 0.041 %
- Remarks on result:
- other: 0.5 - 24 h
- Remarks:
- Percentage penitration
- Conversion factor human vs. animal skin:
- no data
Any other information on results incl. tables
Penetration rate (0 -24 h) 0.003 µg/cm2/h.
Applicant's summary and conclusion
- Conclusions:
- The amount of crinipan systematically available from a standard shampoo formulation containg 2% was found to be 0.297 µg/cm2 (0.15%) after a 30 minute exposure period and 24 hours sampling period.
- Executive summary:
The penetration and distribution of crinipan from a shampoo formulation was measured in vitro through human dermatomed skin. A nominal 2% formulation was prepared and applied by weight at approximately 10 mg/cm2 (or 25.4 mg/cell; 200 μg crinipan/cm2) for an exposure period of 0.5 h and then washed off with a mild soap solution. Samples of receptor fluid were taken at recorded intervals up to 24 h and the skin was unoccluded throughout. This application was designed to simulate potential human dermal exposure to the formulation during normal use. The penetration of crinipan was measured using [14C]crinipan, which was incorporated with the crinipan standard material, prior to mixing with the shampoo formulation, to give a specific activity of approximately 10 MBq/g. The distribution of crinipan within the test system and a 24 h penetration profile were determined. The samples were analysed by LSC.
There was no penetration of crinipan through human skin during the 0.5 h contact period from the 2% shampoo formulation into the receptor fluid. Almost all the applied dose was washed off at 0.5 h (96.9%). A very small proportion of the dose, which had either penetrated into the stratum corneum and epidermis or was not washed off at 0.5 h, penetrated very slowly over the entire 24 h sampling period to give a penetration rate of 0.003 μg/cm2/h. There was a lag phase of approximately 4 h and the fastest rate of penetration was achieved between 6 and 24 h giving an penetration rate of 0.004 μg/cm2/h. At the end of the 24 h sampling period <1% of the applied dose was found in the final wash and <0.2% recovered in the stratum corneum (0.075%) and epidermis (0.109%). The total amount that penetrated into the receptor fluide over 24 h was 0.041% (0.081μg/cm2).
The total amount that penetrated into the receptor fluid over 24 h was 0.041% (0.081μg/cm2).
The amount of crinipan systematically available from a standard shampoo formulation containg 2% was found to be 0.297 µg/cm2 (0.15%).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.